Author

I. Miura

h-index 18 View on Semantic Scholar

We have 3 of 128 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

563. Plasma interleukin-6 levels in antipsychotic-responsive and treatment-resistant schizophrenia in association with clozapine treatment

Abstract Background Neuroinflammation has been proposed as a key pathophysiological mechanism underlying treatment-resistant schizophrenia (TRS). Interleukin-6 (IL-6) has been reported as a trait-related inflammatory marker in schizophrenia; however, data focusing specifically on TRS and the impact of clozapine treatme...

Y. Suzuki, K. Endo, S. Yokokawa et al. · International Journal of Neu... · 0 citations

Oct 2026

Plasma interleukin-6 levels and treatment responses to antipsychotics in schizophrenia: Focus on clozapine treatment.

Neuroinflammation is a key pathophysiological mechanism underlying treatment-resistant schizophrenia (TRS). Interleukin (IL)-6 is a trait-related biomarker that exhibits consistently elevated levels in schizophrenia. However, studies focusing on TRS and examining the associations of clozapine treatment with inflammator...

Yuhei Suzuki, Kota Endo, Shuuho Yokokawa et al. · Psychiatry Research · 0 citations

Open access Aug 2026

Psychiatric-onset prodromal dementia with lewy bodies: a comparative analysis of two cases.

Two women with psychiatric-onset prodromal DLB presentations who were followed longitudinally at a single institution highlight the heterogeneity of psychiatric-onset DLB and the importance of careful longitudinal reassessment in older adults with new-onset psychiatric symptoms.

Yuka Iwasaki, Yuhei Mori, Risa Shishido et al. · Fukushima Journal of Medical... · 0 citations